A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT05181137 · UNKNOWN
Trial details
- NCT number
- NCT05181137
- Sponsor
- Reistone Biopharma Company Limited
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2024-10-31
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.